The Tumor Suppressor Role of the Ras Association Domain Family 10

Author(s): Yulong Hou, Shuofeng Li, Wei Du, Hailong Li, Rumin Wen*

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 20 , Issue 18 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


The Ras association domain family 10(RASSF10), a tumor suppressor gene, is located on human chromosome 11p15.2, which is one of the members homologous to other N-terminal RASSF families obtained through structural prediction. RASSF10 plays an important role in inhibiting proliferation, invasion, and migration, inducing apoptosis, making cancer cells sensitive to docetaxel, and capturing G2/M phase. Some studies have found that RASSF10 may inhibit the occurrence and development of tumors by regulating Wnt/β-catenin, P53, and MMP2. Methylation of tumor suppressor gene promoter is a key factor in the development and progression of many tumors. Various methylation detection methods confirmed that the methylation and downregulation of RASSF10 often occur in various tumors, such as gastric cancer, lung cancer, colon cancer, breast cancer, and leukemia. The status of RASSF10 methylation is positively correlated with tumor size, tumor type, and TNM stage. RASSF10 methylation can be used as a prognostic factor for overall survival and disease-free survival, and is also a sign of tumor diagnosis and sensitivity to docetaxel chemotherapy. In this review, we mainly elucidate the acknowledged structure and progress in the verified functions of RASSF10 and the probably relevant signaling pathways.

Keywords: RASSF10, tumor suppressor, promoter hypermethylation, therapeutic target, function, mechanism.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 23 November, 2020
Page: [2207 - 2215]
Pages: 9
DOI: 10.2174/1871520620666200714141906
Price: $65

Article Metrics

PDF: 19